Tag: Nasdaq:STSA
Satsuma Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results...
Announced updated STS101 development plan featuring a new Phase 3 efficacy trial scheduled to begin enrollment mid-2021 with topline results expected in second...